Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury

Journal of Clinical Oncology

Volumn 28, Issue 15, 2010, Pages 2549-2555

  Overman, Michael J ^a   Maru, Dipen M ^a   Charnsangavej, Chusilp ^a   Loyer, Evelyn M ^a   Wang, Huamin ^a   Pathak, Priyanka ^a   Eng, Cathy ^a   Hoff, Paulo M ^a   Vauthey, Jean Nicolas ^a   Wolff, Robert A ^a   Kopetz, Scott ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CAPECITABINE; FLUOROPYRIMIDINE; FLUOROURACIL; OXALIPLATIN; ANTINEOPLASTIC AGENT; PLATINUM COMPLEX;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; COLON ADENOCARCINOMA; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER INJURY; LIVER METASTASIS; LIVER RESECTION; LIVER SINUSOID; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RECTUM CARCINOMA; RETROSPECTIVE STUDY; SPLEEN SIZE; SPLENOMEGALY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; UNIVARIATE ANALYSIS; BLOOD; CHEMICALLY INDUCED DISORDER; COLON TUMOR; DRUG EFFECT; LIVER VEIN OBSTRUCTION; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RECTUM TUMOR; SPLEEN; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; COLONIC NEOPLASMS; FEMALE; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; PLATELET COUNT; PROGNOSIS; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; SPLEEN; SPLENOMEGALY; TREATMENT OUTCOME;

EID: 77956399254     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.27.5701     Document Type: Article

References (37)

1. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2008. CA Cancer J Clin 58:71-96, 2008
2. Rubbia-Brandt L, Audard V, Sartoretti P, et al: Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 15: 460-466, 2004 (Pubitemid 38444550)
3. Aloia T, Sebagh M, Plasse M, et al: Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol 24:4983-4990, 2006 (Pubitemid 46631400)
4. Karoui M, Penna C, Amin-Hashem M, et al: Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 243:1-7, 2006 (Pubitemid 43054046)
5. Mehta NN, Ravikumar R, Coldham CA, et al: Effect of preoperative chemotherapy on liver resection for colorectal liver metastases. Eur J Surg Oncol 34:782-786, 2008
6. Nakano H, Oussoultzoglou E, Rosso E, et al: Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg 247:118-124, 2008
7. Vauthey JN, Pawlik TM, Ribero D, et al: Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24:2065-2072, 2006 (Pubitemid 46622116)
8. DeLeve LD, Wang X, Kuhlenkamp JF, et al: Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: The role of glutathione and relevance to hepatic venoocclusive disease. Hepatology 23:589-599, 1996 (Pubitemid 26087175)
9. Ishizaki T, Abe T, Koyanagi Y, et al: A case of liver failure associated with liver damage due to mFOLFOX 6 after resection for multiple liver metastases from colorectal cancer (Japanese). Gan To Kagaku Ryoho 34:945-948, 2007
10. Schouten van der Velden AP, Punt CJ, Van Krieken JH, et al: Hepatic veno-occlusive disease after neoadjuvant treatment of colorectal liver metastases with oxaliplatin: A lesson of the month. Eur J Surg Oncol 34:353-355, 2008
11. Arotcarena R, Cales V, Berthelemy P, et al: Severe sinusoidal lesions: A serious and overlooked complication of oxaliplatin-containing chemotherapy? Gastroenterol Clin Biol 30:1313-1316, 2006
12. Tisman G, MacDonald D, Shindell N, et al: Oxaliplatin toxicity masquerading as recurrent colon cancer. J Clin Oncol 22:3202-3204, 2004
13. Agarwal V, Sgouros J, Smithson J, et al: Sinusoidal obstruction syndrome (veno-occlusive disease) in a patient receiving bevacizumab for metastatic colorectal cancer: A case report. J Med Case Reports 2:227, 2008
14. Slade JH, Alattar ML, Fogelman DR, et al: Portal hypertension associated with oxaliplatin administration: Clinical manifestations of hepatic sinusoidal injury. Clin Colorectal Cancer 8:225-230, 2009
15. Kandutsch S, Klinger M, Hacker S, et al: Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases. Eur J Surg Oncol 34:1231-1236, 2008
16. Prassopoulos P, Daskalogiannaki M, Raissaki M, et al: Determination of normal splenic volume on computed tomography in relation to age, gender and body habitus. Eur Radiol 7:246-248, 1997 (Pubitemid 127538590)
17. Greenland S: Alternative models for ordinal logistic regression. Stat Med 13:1665-1677, 1994
18. Andre T, Boni C, Mounedji-Boudiaf L, et al: Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350:2343-2351, 2004 (Pubitemid 38702845)
19. Colucci G, Gebbia V, Paoletti G, et al: Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: A multicenter study of the Gruppo Oncologico Dell'Italia Meridionale. J Clin Oncol 23:4866-4875, 2005 (Pubitemid 46223991)
20. Kauffman CR, Mahvash A, Kopetz S, et al: Partial splenic embolization for cancer patients with thrombocytopenia requiring systemic chemotherapy. Cancer 112:2283-2288, 2008 (Pubitemid 351628640)
21. Curtis BR, Kaliszewski J, Marques MB, et al: Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin. Am J Hematol 81:193-198, 2006
22. Dold FG, Mitchell EP: Sudden-onset thrombocytopenia with oxaliplatin. Ann Intern Med 139: E156-E157, 2003
23. Pavic M, Moncharmont P, Seve P, et al: Oxaliplatin-induced immune thrombocytopenia. Gastroenterol Clin Biol 30:797-798, 2006
24. Sorbye H, Bruserud Y, Dahl O: Oxaliplatininduced haematological emergency with an immediate severe thrombocytopenia and haemolysis. Acta Oncol 40:882-883, 2001 (Pubitemid 34081671)
25. Taleghani BM, Meyer O, Fontana S, et al: Oxaliplatin-induced immune pancytopenia. Transfusion 45:704-708, 2005
26. Angitapalli R, Litwin AM, Kumar PR, et al: Adjuvant FOLFOX chemotherapy and splenomegaly in patients with stages II-III colorectal cancer. Oncology 76:363-368, 2009
27. Nordlinger B, Sorbye H, Glimelius B, et al: Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): A randomised controlled trial. Lancet 371:1007-1016, 2008 (Pubitemid 351392040)
28. Brouquet A, Benoist S, Julie C, et al: Risk factors for chemotherapy-associated liver injuries: A multivariate analysis of a group of 146 patients with colorectal metastases. Surgery 145:362-371, 2009
29. Julie C, Lutz MP, Aust D, et al: Pathological analysis of hepatic injury after oxaliplatin-based neoadjuvant chemotherapy of colorectal cancer liver metastases: Results of the EORTC Intergroup phase III study 40983. Presented at the ASCO GI Symposium, Orlando, FL, January 19-21, 2007
30. Ward J, Guthrie JA, Sheridan MB, et al: Sinusoidal obstructive syndrome diagnosed with superparamagnetic iron oxide-enhanced magnetic resonance imaging in patients with chemotherapy-treated colorectal liver metastases. J Clin Oncol 26:4304-4310, 2008
31. O'Rourke TR, Welsh FK, Tekkis PP, et al: Accuracy of liver-specific magnetic resonance imaging as a predictor of chemotherapy-associated hepatic cellular injury prior to liver resection. Eur J Surg Oncol 35:1085-1091, 2009
32. Klinger M, Eipeldauer S, Hacker S, et al: Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases. Eur J Surg Oncol 35: 515-520, 2009
33. Ribero D, Wang H, Donadon M, et al: Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases. Cancer 110:2761-2767, 2007 (Pubitemid 350250347)
34. Slade HJ AM, Fogelman DR, et al: Portal hypertension associated with oxaliplatin administration: Clinical manifestations of hepatic sinusoidal injury. Clin Colorectal Cancer 8:225-230, 2009
35. Bilchik AJ, Poston G, Curley SA, et al: Neoadjuvant chemotherapy for metastatic colon cancer: A cautionary note. J Clin Oncol 23:9073-9078, 2005
36. Nordlinger B, Benoist S: Benefits and risks of neoadjuvant therapy for liver metastases. J Clin Oncol 24:4954-4955, 2006 (Pubitemid 46631395)
37. Zorzi D, Laurent A, Pawlik TM, et al: Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 94:274-286, 2007 (Pubitemid 46423843)